These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23004340)

  • 1. P2Y purinoceptors as potential emerging therapeutical target in vascular disease.
    Schuchardt M; Tölle M; van der Giet M
    Curr Pharm Des; 2012; 18(37):6169-80. PubMed ID: 23004340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pharmacology of P2Y receptor subtypes.
    von Kügelgen I
    Biochem Pharmacol; 2021 May; 187():114361. PubMed ID: 33309519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors.
    Zhou Z; Chrifi I; Xu Y; Pernow J; Duncker DJ; Merkus D; Cheng C
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H299-309. PubMed ID: 27233766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2Y/P2X divide: How it began.
    Kennedy C
    Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X and P2Y nucleotide receptors as targets in cardiovascular disease.
    Kennedy C; Chootip K; Mitchell C; Syed NI; Tengah A
    Future Med Chem; 2013 Mar; 5(4):431-49. PubMed ID: 23495690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.
    Weisman GA; Woods LT; Erb L; Seye CI
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):722-38. PubMed ID: 22963441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells.
    Raqeeb A; Sheng J; Ao N; Braun AP
    Cell Calcium; 2011 Apr; 49(4):240-8. PubMed ID: 21414662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of P2-purinoceptors in the cardiovascular system.
    Ralevic V; Burnstock G
    Circulation; 1991 Jul; 84(1):1-14. PubMed ID: 1647896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation.
    Guo X; Li Q; Pi S; Xia Y; Mao L
    Biochem Pharmacol; 2021 Oct; 192():114689. PubMed ID: 34274353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification.
    Schuchardt M; Tölle M; Prüfer J; Prüfer N; Huang T; Jankowski V; Jankowski J; Zidek W; van der Giet M
    Kidney Int; 2012 Feb; 81(3):256-65. PubMed ID: 21956191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended tool compounds and drugs for blocking P2X and P2Y receptors.
    Müller CE; Namasivayam V
    Purinergic Signal; 2021 Dec; 17(4):633-648. PubMed ID: 34476721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y purinoceptors mediate ATP-induced changes in intracellular calcium and amylase release in acinar cells of mouse parotid glands.
    Moriguchi-Mori K; Higashio H; Isobe K; Kumagai M; Sasaki K; Satoh Y; Kuji A; Saino T
    Biomed Res; 2016; 37(1):37-49. PubMed ID: 26912139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic mass redistribution assays decode surface influence on signaling of endogenous purinergic P2Y receptors.
    Tran E; Sun H; Fang Y
    Assay Drug Dev Technol; 2012 Feb; 10(1):37-45. PubMed ID: 22066912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biphasic response of rat vesical smooth muscle to ATP.
    Bolego C; Pinna C; Abbracchio MP; Cattabeni F; Puglisi L
    Br J Pharmacol; 1995 Apr; 114(8):1557-62. PubMed ID: 7599923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic transmission in blood vessels.
    Ralevic V; Dunn WR
    Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of P2 receptors on pancreatic β-cells by agonists and antagonists: a molecular target for type 2 diabetes treatment.
    Pacheco PA; Ferreira LG; Alves LA; Faria RX
    Curr Diabetes Rev; 2013 May; 9(3):228-36. PubMed ID: 23506378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation of fluorophore-conjugated phalloidin into live hair cells of the inner ear is modulated by P2Y receptors.
    Thiede BR; Corwin JT
    J Assoc Res Otolaryngol; 2014 Feb; 15(1):13-30. PubMed ID: 24263968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of Macrophage Inflammation by P2Y Purinergic Receptors.
    Klaver D; Thurnher M
    Cells; 2021 May; 10(5):. PubMed ID: 34064383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.